Daniel Guldager Kring Rasmussen

2.0k total citations
45 papers, 777 citations indexed

About

Daniel Guldager Kring Rasmussen is a scholar working on Nephrology, Immunology and Allergy and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Daniel Guldager Kring Rasmussen has authored 45 papers receiving a total of 777 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 9 papers in Immunology and Allergy and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Daniel Guldager Kring Rasmussen's work include Chronic Kidney Disease and Diabetes (13 papers), Cell Adhesion Molecules Research (9 papers) and Protease and Inhibitor Mechanisms (6 papers). Daniel Guldager Kring Rasmussen is often cited by papers focused on Chronic Kidney Disease and Diabetes (13 papers), Cell Adhesion Molecules Research (9 papers) and Protease and Inhibitor Mechanisms (6 papers). Daniel Guldager Kring Rasmussen collaborates with scholars based in Denmark, United Kingdom and United States. Daniel Guldager Kring Rasmussen's co-authors include M.A. Karsdal, Federica Genovese, Signe Holm Nielsen, Diana Julie Leeming, Martin Tepel, Mette Juul Nielsen, Tine W. Hansen, Diane E. Shevell, Yi Luo and Peter Rossing and has published in prestigious journals such as PLoS ONE, Diabetes Care and Scientific Reports.

In The Last Decade

Daniel Guldager Kring Rasmussen

42 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Guldager Kring Rasmussen Denmark 15 255 153 151 148 114 45 777
Toshihiro Shimizu Japan 15 115 0.5× 89 0.6× 65 0.4× 402 2.7× 123 1.1× 64 910
Natasha Barascuk Denmark 15 139 0.5× 125 0.8× 41 0.3× 215 1.5× 99 0.9× 20 766
Elsie Oppermann Germany 19 166 0.7× 123 0.8× 23 0.2× 304 2.1× 146 1.3× 58 997
Toru Sakairi Japan 18 171 0.7× 36 0.2× 283 1.9× 363 2.5× 111 1.0× 50 957
A Fukatsu Japan 20 81 0.3× 69 0.5× 225 1.5× 273 1.8× 271 2.4× 41 1.1k
Hiroko Kanda Japan 18 112 0.4× 24 0.2× 105 0.7× 130 0.9× 74 0.6× 55 823
Yoshiro Ishiwata Japan 12 77 0.3× 31 0.2× 255 1.7× 248 1.7× 156 1.4× 19 1.0k
Linda Ertl United States 12 122 0.5× 33 0.2× 168 1.1× 138 0.9× 61 0.5× 27 904
Xiaoping Qing United States 15 64 0.3× 43 0.3× 199 1.3× 237 1.6× 41 0.4× 23 1.1k
Antonia Loverre Italy 17 93 0.4× 41 0.3× 249 1.6× 258 1.7× 274 2.4× 21 1.1k

Countries citing papers authored by Daniel Guldager Kring Rasmussen

Since Specialization
Citations

This map shows the geographic impact of Daniel Guldager Kring Rasmussen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Guldager Kring Rasmussen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Guldager Kring Rasmussen more than expected).

Fields of papers citing papers by Daniel Guldager Kring Rasmussen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Guldager Kring Rasmussen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Guldager Kring Rasmussen. The network helps show where Daniel Guldager Kring Rasmussen may publish in the future.

Co-authorship network of co-authors of Daniel Guldager Kring Rasmussen

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Guldager Kring Rasmussen. A scholar is included among the top collaborators of Daniel Guldager Kring Rasmussen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Guldager Kring Rasmussen. Daniel Guldager Kring Rasmussen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alkaff, Firas Farisi, Daan Kremer, Daniel Guldager Kring Rasmussen, et al.. (2025). Urinary endotrophin as a biomarker for T cell–mediated rejection-associated fibrogenesis in kidney transplant recipients. Clinical Kidney Journal. 18(11). sfaf301–sfaf301.
2.
Rasmussen, Daniel Guldager Kring, Peder Frederiksen, Yunyun Luo, et al.. (2024). Association of type III collagen turnover with cardiovascular outcomes and impact with canagliflozin in the CANVAS Program: A post hoc analysis. Diabetes Obesity and Metabolism. 26(9). 4060–4068. 3 indexed citations
3.
Alkaff, Firas Farisi, Daan Kremer, Olivier Thaunat, et al.. (2024). Urinary Endotrophin and Long-term Outcomes in Kidney Transplant Recipients. Transplantation Direct. 10(3). e1591–e1591. 1 indexed citations
4.
Genovese, Federica, Daniel Guldager Kring Rasmussen, M.A. Karsdal, et al.. (2023). Endotrophin Levels Are Associated with Allograft Outcomes in Kidney Transplant Recipients. Biomolecules. 13(5). 792–792. 5 indexed citations
5.
Rasmussen, Daniel Guldager Kring, Federica Genovese, Pernille Falberg Rønn, et al.. (2023). Endotrophin as a risk marker of mortality and kidney complications in a type 1 diabetes cohort. Frontiers in Molecular Biosciences. 10. 1229579–1229579. 1 indexed citations
6.
Rasmussen, Daniel Guldager Kring, Federica Genovese, Tine W. Hansen, et al.. (2023). Marker for kidney fibrosis is associated with inflammation and deterioration of kidney function in people with type 2 diabetes and microalbuminuria. PLoS ONE. 18(3). e0283296–e0283296. 9 indexed citations
7.
Hansen, Christian Stevns, Daniel Guldager Kring Rasmussen, Tine W. Hansen, et al.. (2023). Collagen turnover is associated with cardiovascular autonomic and peripheral neuropathy in type 1 diabetes: novel pathophysiological mechanism?. Cardiovascular Diabetology. 22(1). 158–158. 3 indexed citations
8.
Tepel, Martin, Firas Farisi Alkaff, Daan Kremer, et al.. (2022). Pretransplant endotrophin predicts delayed graft function after kidney transplantation. Scientific Reports. 12(1). 4079–4079. 10 indexed citations
9.
Kremer, Daan, Firas Farisi Alkaff, Adrian Post, et al.. (2022). Plasma endotrophin, reflecting tissue fibrosis, is associated with graft failure and mortality in KTRs: results from two prospective cohort studies. Nephrology Dialysis Transplantation. 38(4). 1041–1052. 4 indexed citations
10.
Rasmussen, Daniel Guldager Kring, Quentin M. Anstee, Richard Torstenson, et al.. (2022). NAFLD and NASH biomarker qualification in the LITMUS consortium – Lessons learned. Journal of Hepatology. 78(4). 852–865. 20 indexed citations
11.
Tepel, Martin, Olivier Thaunat, Stephan J. L. Bakker, et al.. (2022). Pretransplant characteristics of kidney transplant recipients that predict posttransplant outcome. Frontiers in Immunology. 13. 945288–945288. 5 indexed citations
12.
Nielsen, Mette Juul, Diana Julie Leeming, Zachary Goodman, et al.. (2021). Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population. Journal of Hepatology. 75(6). 1292–1300. 42 indexed citations
13.
Reese‐Petersen, Alexander Lynge, et al.. (2020). An In Vitro Model to Elucidate the Synthesis of Extracellular Matrix Proteins Involved in Renal Interstitial Fibrosis. Journal of the American Society of Nephrology. 31(10S). 233–233. 1 indexed citations
14.
Karsdal, M.A., Sara Toftegaard Hjuler, Yi Luo, et al.. (2018). Assessment of liver fibrosis progression and regression by a serological collagen turnover profile. American Journal of Physiology-Gastrointestinal and Liver Physiology. 316(1). G25–G31. 42 indexed citations
15.
Rasmussen, Daniel Guldager Kring, Tine W. Hansen, Bernt Johan von Scholten, et al.. (2018). Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria. Diabetes Care. 41(7). 1493–1500. 46 indexed citations
16.
Stemann, Jakob Hjorth von, Andreas S. Rigas, Lise Wegner Thørner, et al.. (2017). Prevalence and correlation of cytokine-specific autoantibodies with epidemiological factors and C-reactive protein in 8,972 healthy individuals: Results from the Danish Blood Donor Study. PLoS ONE. 12(6). e0179981–e0179981. 34 indexed citations
17.
Rasmussen, Daniel Guldager Kring, Saleh Yazdani, Gerjan Navis, et al.. (2017). Urinary collagen degradation products as early markers of progressive renal fibrosis. Journal of Translational Medicine. 15(1). 63–63. 35 indexed citations
18.
Rasmussen, Daniel Guldager Kring, Anthony Fenton, Mark Jesky, et al.. (2017). Urinary endotrophin predicts disease progression in patients with chronic kidney disease. Scientific Reports. 7(1). 17328–17328. 53 indexed citations
19.
Rasmussen, Daniel Guldager Kring, Jakob Hjorth von Stemann, Rune Larsen, et al.. (2015). A rapid, accurate and robust particle-based assay for the simultaneous screening of plasma samples for the presence of five different anti-cytokine autoantibodies. Journal of Immunological Methods. 425. 62–68. 12 indexed citations
20.
Rasmussen, Daniel Guldager Kring, Annie Bremmelgaard, Finn Rasmussen, & Jørgen Thorup. (1986). Treatment of serious urological infections with cefotaxime compared to ampicillin plus netilmicin.. PubMed. 33(1). 49–51. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026